Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Amneal Pharmaceuticals Inc Class A (AMRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Amneal Pharma A's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.360 -0.100    -1.83%
16:00:01 - Closed. Currency in USD ( Disclaimer )
After Hours
5.490
+0.130
+2.425%
18:29:18 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 816,073
  • Bid/Ask: 5.300 / 5.490
  • Day's Range: 5.340 - 5.470
Amneal Pharma A 5.360 -0.100 -1.83%

Amneal Pharma A (AMRX) Earnings Dates & Reports

 
On this page, you can find detailed information about the financial performance of Impax Labs, including the latest Impax Labs earnings report and upcoming earnings date. The page provides an overview of the company's financial health, with key data points such as the current stock price, earnings per share, and revenue compared against the forecast.
InvestingPro Earnings Insights
Latest Release

Mar 01, 2024

EPS / Forecast

0.14 / 0.09

Revenue / Forecast

617M / 634.89M

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Aug 05, 2024 06/2024 -- /  0.1329 -- /  653.02M
May 03, 2024 03/2024 -- /  0.0926 -- /  620.31M
Mar 01, 2024 12/2023 0.14 /  0.09 617M /  634.89M
Nov 07, 2023 09/2023 0.19 /  0.13 620.04M /  590.62M
Aug 04, 2023 06/2023 0.19 /  0.1 599M /  565.11M
May 05, 2023 03/2023 0.12 /  0.09 558M /  542.27M
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View upcoming earnings forecasts and in-depth analysis of company forecasts.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AMRX Comments

Write your thoughts about Amneal Pharmaceuticals Inc Class A
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nikunj Patel
Nikunj Patel Mar 31, 2023 6:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great entry point. Q3-Q4 target $2.25-2.75
Alexandru Eva
Alexandru Eva Nov 23, 2021 4:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
BUY
Despoina Alterlife
Despoina Alterlife Nov 23, 2021 4:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
are you still here my Eva ?
Zoran Labus
Zoran Labus Mar 25, 2021 11:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
Robert Nicholas
Robert Nicholas Mar 05, 2021 1:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think its got a shot , they make a lot of money for how cheap they are.
burnett bryant
burnett bryant Feb 04, 2021 11:33PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Charles Resheske
Charles Resheske Dec 03, 2020 7:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
breakout up trend buy
Ante Parcina
Ante Parcina Nov 06, 2020 5:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ready to fly
Sorin Costache
Sorin Costache Sep 12, 2020 9:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to buy!
Istvan Nagy
Istvan Nagy Aug 06, 2020 10:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why did it drop 12% after a better than expected earnings report??
Matija Ivic
Matija Ivic Aug 06, 2020 10:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I was also suprised. Anyone have any information?
Оля Раваева
Оля Раваева Aug 06, 2020 10:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Maybe there is some undisclosed information?
Jaafar Abu
Jaafar Abu Jul 16, 2020 6:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Paolo gerosa why you say see you at 13? Its possible to get 13? What is your opinion ?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email